IL17A and rheumatoid arthritis: Inflammatory factors produced systemically and in the joint, such as IL-17, could induce damage in the gut tissue to exacerbate disease pathology, but a breach of tolerance at mucosal surfaces is thought to be an initial event in RA that can occur many years before disease onset.